These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 6317860)

  • 1. Synthesis, resolution, absolute stereochemistry, and enantioselectivity of 3',4'-dihydroxynomifensine.
    Dandridge PA; Kaiser C; Brenner M; Gaitanopoulos D; Davis LD; Webb RL; Foley JJ; Sarau HM
    J Med Chem; 1984 Jan; 27(1):28-35. PubMed ID: 6317860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Absolute stereochemistry and dopaminergic activity of enantiomers of 2,3,4,5-tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine.
    Kaiser C; Dandridge PA; Garvey E; Hahn RA; Sarau HM; Setler PE; Bass LS; Clardy J
    J Med Chem; 1982 Jun; 25(6):697-703. PubMed ID: 6980283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct effect of a nomifensine derivative on dopamine receptors.
    Poat JA; Woodruff GN; Watling KJ
    J Pharm Pharmacol; 1978 Aug; 30(8):495-7. PubMed ID: 28397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resolution, absolute stereochemistry, and enantioselectivity of 2-methyl-4-phenyl-1,2,3,4-tetrahydroisoquinolin-4-ol.
    Kihara M; Kashimoto M; Kobayashi S; Ishida Y; Moritoki H; Taira Z
    J Med Chem; 1990 Aug; 33(8):2283-6. PubMed ID: 2374154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New substituted 1-phenyl-3-benzazepine analogues of SK&F 38393 and N-methyl-thienopyridine analogues of dihydroxynomifensine with selective affinity for the D-1 dopamine receptor in human post-mortem brain.
    O'Boyle KM; Waddington JL
    Neuropharmacology; 1987 Dec; 26(12):1807-10. PubMed ID: 3501846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis of 4-substituted 2H-naphth[1,2-b]-1,4-oxazines, a new class of dopamine agonists.
    Jones JH; Anderson PS; Baldwin JJ; Clineschmidt BV; McClure DE; Lundell GF; Randall WC; Martin GE; Williams M; Hirshfield JM
    J Med Chem; 1984 Dec; 27(12):1607-13. PubMed ID: 6094811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aporphines. 48. Enantioselectivity of (R)-(-)- and (S)-(+)-N-n-propylnorapomorphine on dopamine receptors.
    Neumeyer JL; Reischig D; Arana GW; Campbell A; Baldessarini RJ; Kula NS; Watling KJ
    J Med Chem; 1983 Apr; 26(4):516-21. PubMed ID: 6682147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dopaminergic benzo[a]phenanthridines: resolution and pharmacological evaluation of the enantiomers of dihydrexidine, the full efficacy D1 dopamine receptor agonist.
    Knoerzer TA; Nichols DE; Brewster WK; Watts VJ; Mottola D; Mailman RB
    J Med Chem; 1994 Jul; 37(15):2453-60. PubMed ID: 7914538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and pharmacological characterization of 1-phenyl-, 4-phenyl-, and 1-benzyl-1,2,3,4-tetrahydroisoquinolines as dopamine receptor ligands.
    Charifson PS; Wyrick SD; Hoffman AJ; Simmons RM; Bowen JP; McDougald DL; Mailman RB
    J Med Chem; 1988 Oct; 31(10):1941-6. PubMed ID: 3050089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pyrroloisoquinoline antidepressants. 2. In-depth exploration of structure-activity relationships.
    Maryanoff BE; McComsey DF; Gardocki JF; Shank RP; Costanzo MJ; Nortey SO; Schneider CR; Setler PE
    J Med Chem; 1987 Aug; 30(8):1433-54. PubMed ID: 3039136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-activity relationships in the trans-hexahydroindolo[4,3-ab]phenanthridine ("benzergoline") series. 2. Resolution, absolute configuration, and dopaminergic activity of the selective D1 agonist CY 208-243 and its implication for an "extended rotamer-based dopamine receptor model".
    Seiler MP; Floersheim P; Markstein R; Widmer A
    J Med Chem; 1993 Apr; 36(8):977-84. PubMed ID: 8097540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and enantioselectivity of optically active 1- and 3-substituted 4-phenyl-1,2,3,4-tetrahydroisoquinolin-4-ols and related compounds as norepinephrine potentiators.
    Kihara M; Ikeuchi M; Adachi S; Nagao Y; Moritoki H; Yamaguchi M; Taira Z
    Chem Pharm Bull (Tokyo); 1995 Sep; 43(9):1543-6. PubMed ID: 7586079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis, absolute configuration, and biological profile of the enantiomers of trans-[2-(2,6-dimethoxyphenoxy)ethyl] [(3-p-tolyl-2,3-dihydro-1,4-benzodioxin-2-yl)methyl]amine (mephendioxan), a potent competitive alpha 1A-adrenoreceptor antagonist.
    Quaglia W; Pigini M; Tayebati SK; Piergentili A; Giannella M; Leonardi A; Taddei C; Melchiorre C
    J Med Chem; 1996 May; 39(11):2253-8. PubMed ID: 8667368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. (R)-(-)- and (S)-(+)-Synadenol: synthesis, absolute configuration, and enantioselectivity of antiviral effect.
    Qiu YL; Hempel A; Camerman N; Camerman A; Geiser F; Ptak RG; Breitenbach JM; Kira T; Li L; Gullen E; Cheng YC; Drach JC; Zemlicka J
    J Med Chem; 1998 Dec; 41(26):5257-64. PubMed ID: 9857093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective labeling of alpha-adrenergic receptors in caudate nucleus by [3H] dihydroergocryptine in the presence of spiperone-blocked dopamine receptors.
    Titeler M; Seeman P
    Proc Natl Acad Sci U S A; 1978 May; 75(5):2249-53. PubMed ID: 27786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dopaminergic properties of nomifensine.
    Gianutsos G; Morrow G; Light S; Sweeney MJ
    Pharmacol Biochem Behav; 1982 Nov; 17(5):951-4. PubMed ID: 6294689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of bromocriptine on 3H-spiroperidol binding sites in rat striatum. Evidence for actions of dopamine receptors not linked to adenylate cyclase.
    Schwarcz R; Fuxe K; Agnati LF; Gustafsson JA
    Life Sci; 1978 Aug; 23(5):465-9. PubMed ID: 692269
    [No Abstract]   [Full Text] [Related]  

  • 18. Characterization of dopamine autoreceptor and [3H]spiperone binding sites in vitro with classical and novel dopamine receptor agonists.
    Lehmann J; Briley M; Langer SZ
    Eur J Pharmacol; 1983 Mar; 88(1):11-26. PubMed ID: 6133762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of 3',4'-dihydroxynomifensine on the dopamine vascular receptor.
    Kohli JD; Goldberg LI
    J Pharm Pharmacol; 1980 Mar; 32(3):225-6. PubMed ID: 6103946
    [No Abstract]   [Full Text] [Related]  

  • 20. Synthesis, conformation, and dopaminergic activity of 5,6-ethano-bridged derivatives of selective dopaminergic 3-benzazepines.
    Weinstock J; Oh HJ; DeBrosse CW; Eggleston DS; Wise M; Flaim KE; Gessner GW; Sawyer JL; Kaiser C
    J Med Chem; 1987 Aug; 30(8):1303-8. PubMed ID: 2886663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.